Adjuvant chemotherapy for the ''Oldest Old'' ovarian cancer patients: Can we anticipate toxicity-related treatment failure in a vulnerable population?

Cancer

Volumn 115, Issue 7, 2009, Pages 1472-1480

  Moore, Kathleen N ^a   Frank, Summer G ^b   Alward, Erin K ^a   Landrum, Lisa M ^a   Myers, Tashanna K ^a   L Walker, Joan ^a   Gold, Michael A ^a   McMeekin, D Scott ^a   Vesely, Sara K ^b   Mannel, Robert S ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Chemotherapy; Elderly patient; Ovarian cancer; Toxicity

Indexed keywords

PACLITAXEL; PLATINUM DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; BODY WEIGHT; CANCER ADJUVANT THERAPY; CONSTIPATION; CONTROLLED STUDY; CREATININE CLEARANCE; CYTOREDUCTIVE SURGERY; DEPRESSION; DIARRHEA; EATING DISORDER; ELDERLY CARE; FATIGUE; FEMALE; FEVER; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NATIONAL HEALTH ORGANIZATION; NAUSEA; NEUTROPENIA; OVARY CANCER; PAIN; PARESTHESIA; PREDICTION; PRIORITY JOURNAL; SELF REPORT; SKIN TINGLING; STOMATITIS; THROMBOCYTOPENIA; TINNITUS; VISUAL DISORDER; VOMITING;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CREATININE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 63449091964     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24190     Document Type: Article

References (18)

1. Bouchardy C, Rapiti E, Blagojevic S, Vlastos AT, Vlastos G. Older female cancer patients: importance, causes, and consequences of under treatment. J Clin Oncol. 2007;25:1858-1869.
2. Moore DH, Kauderer JT, Bell J, Curtin JP, Van Le L. An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group Study. Gynecol Oncol. 2004;94:368-374.
3. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL. Patterns of chemotherapy use for women with ovarian cancer: a population based study. J Clin Oncol. 2003;21:1530-1535.
4. Bruchim I, Altaras M, Fishman A. Age contrasts in clinical characteristics and patterns of care in patients with epithelial ovarian cancer. Gynecol Oncol. 2002;86:274-278.
5. Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol. 2003;21:3488-3494.
6. Hetzel L, Smith A. The 65 years and over population: 2000. Census 2000 Brief. Available at: http://www.census.gov. Issued October 2001.
7. National Cancer Institute. Common Toxicity Criteria. Version 3. Bethesda, MD: National Cancer Institute; March 31, 2003. Available at: http://www.fda.gov/cder/cancer/toxicityframe.htm. Last updated August 9, 2006.
8. Moore KN, Reid MS, Fong DN, et al. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytore-ductive surgery and chemotherapy still apply? Gynecol Oncol. 2008;110:133-139.
9. Armstrong DK, Bundy BN, Nenzel L, et al. Interperito- neal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34-43.
10. Copeland LJ, Bookman M, Trimble E. Clinical trials of newer regimens for treating ovarian cancer: the rationale for gynecologic oncology group protocol GOG 182-ICON 5. Gynecol Oncol. 2003;90:51-57.
11. Yancik R, Ries LA. Aging and cancer in America: demographic and epidemiologic perspectives. Hematol Oncol Clin North Am. 2000;14:17-24.
12. Arias E. United States Life Tables, 2003. Natl Vital Stat Rep. 2006;54:1-40.
13. Uyar D, Frasure HE, Marman M, von Gruenigen VE. Treatment patterns by decade of life in elderly women (>70 years of age) with ovarian cancer. Gynecol Oncol. 2005;98:403-408.
14. Yancik R, Gloeckler Ries L, Yates JW. Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology and End Results Program data. Am J Obstet Gynecol. 1986;154: 639-647.
15. Hightower RD, Nguyen HN, Averette HE, Hoskins W, Harrison T, Steren A. National survey of ovarian carcinoma. IV: patterns of care and related survival for older patients. Cancer. 1994;73:377-383.
16. Cloven NG, Manetta A, Berman ML, Kohler MF, DiSaia PJ. Management of ovarian cancer in patients older than 80 years of age. Gynecol Oncol. 1999;73:137-139.
17. Sundararajan V, Hershman D, Grann VR, Jacobson JS, Neugut AI. Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population based study. J Clin Oncol. 2002;20:173-178.
18. Hurria A, Lichtman SM. Pharmacokinetics of chemotherapy in the older patient. Cancer Control. 2007;14:32-43.